Similar findings of GSK-3β inhibition were described for glioblastoma, in which a reduction of stem cell markers was described upon GSK-3β inhibition subsequently leading to impaired neurosphere formation and lessened clonogenicity [26, 27]. The gene discussed is GSK3B; the disease is glioblastoma.